Akebia
Cambridge, US · 1 known investors
Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease. The company is a fully integrated biopharmaceutical organization with a nephrology-focused commercial team and development capabilities.
Founders & leadership
JP
John P. ButlerPresident and Chief Executive Officer